ribavirin aurovitas 200 mg tabletki powlekane
aurovitas pharma polska sp. z o.o. - ribavirinum - tabletki powlekane - 200 mg
ribavirin teva pharma b.v.
teva b.v. - rybawiryna - wirusowe zapalenie wątroby typu c, przewlekłe - Środki przeciwwirusowe do użytku ogólnoustrojowego - ribavirin teva pharma b. is indicated in combination with other medicinal products for the treatment ofchronic hepatitis c (chc) in adults (see sections 4. 2, 4. 4 i 5. ribavirin teva pharma b. is indicated in combination with other medicinal products for the treatment ofchronic hepatitis c (chc) for paediatric patients (children 3 years of age and older and adolescents) notpreviously treated and without liver decompensation (see sections 4. 2, 4. 4 i 5.
copegus 200 mg tabletki powlekane
roche polska sp. z o.o. - ribavirinum - tabletki powlekane - 200 mg
copegus 400 mg tabletki powlekane
roche polska sp. z o.o. - ribavirinum - tabletki powlekane - 400 mg
moderiba 200 mg tabletki powlekane
abbvie polska sp. z o.o. - povidonum + ribavirinum - tabletki powlekane - 200 mg
moderiba 400 mg tabletki powlekane
abbvie polska sp. z o.o. - ribavirinum - tabletki powlekane - 400 mg
moderiba 600 mg tabletki powlekane
abbvie polska sp. z o.o. - ribavirinum - tabletki powlekane - 600 mg
revolade
novartis europharm limited - olamine - purpura, trombocytopenic, idiopatyczny - other systemic hemostatics, antihemorrhagics - revolade is indicated for the treatment of adult patients with primary immune thrombocytopenia (itp) who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 i 5. revolade is indicated for the treatment of paediatric patients aged 1 year and above with primary immune thrombocytopenia (itp) lasting 6 months or longer from diagnosis and who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 i 5. revolade is indicated in adult patients with chronic hepatitis c virus (hcv) infection for the treatment of thrombocytopenia, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy (see sections 4. 4 and 5. revolade is indicated in adult patients with acquired severe aplastic anaemia (saa) who were either refractory to prior immunosuppressive therapy or heavily pretreated and are unsuitable for haematopoietic stem cell transplantation (see section 5.
aspirin c 400 mg + 240 mg tabletki musujące
pharmavitae sp. z o.o. sp. k. - acidum acetylsalicylicum + acidum ascorbicum + peginterferonum alfa-2b - tabletki musujące - 400 mg + 240 mg
normatens 5 mg + 0,5 mg + 0,1 mg tabletki drażowane
delfarma sp. z o.o. - clopamidum + dihydroergocristinum + reserpinum + peginterferonum alfa-2b - tabletki drażowane - 5 mg + 0,5 mg + 0,1 mg